Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb(TM)) as a vasopressor in critically ill patients

Critical Care Medicine

Volumn 25, Issue 9, 1997, Pages 1480-1488

  Reah, Gary ^a   Bodenham, Andrew R ^a   Mallick, Abhiram ^a   Daily, Elaine K ^b   Przybelski, Robert J ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Blood substitute; DCLHb(TM); Diaspirin cross linked hemoglobin; Gastric intramucosal pH; Hemodynamics; Hemoglobin solution; Septic shock; Systemic inflammatory response syndrome; Tonometry; Vasopressor

Indexed keywords

ACETYLSALICYLIC ACID; HYPERTENSIVE FACTOR;

ADULT; ARTICLE; BLOOD SUBSTITUTION; CLINICAL ARTICLE; CRITICAL ILLNESS; CROSS LINKING; DIAGNOSTIC ACCURACY; HEART INDEX; HEMOGLOBIN ANALYSIS; HUMAN; INFLAMMATION; INOTROPISM; PH; PRIORITY JOURNAL; SEPTICEMIA; TONOMETRY; URINE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CREATININE; CRITICAL ILLNESS; DRUG MONITORING; FEMALE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HUMANS; HYPOTENSION; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PLATELET COUNT; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030874733     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199709000-00014     Document Type: Article

References (45)

1. 2). J Biol Chem 1986; 261:9929-9937
2. Vandegriff KD, Medina F, Marini MA, et al: Equilibrium oxygen binding to α-α cross-linked human hemoglobin cross-linked between the α chains by bis(3, 5-dibromosalicyl) fumarate. J Biol Chem 1989; 264:17824-17833
3. Nelson D, Azari M, Brown R, et al: Preparation and characterization of diaspirin cross-linked hemoglobin solutions for pre-clinical studies. Biomat Artif Cells Immob Biotech 1992; 20: 423-427
4. Farmer MA, Ebeling T, Marshall W, et al: Viral inactivation in diaspirin cross-linked hemoglobin solution by heat treatment. Transfusion 1991;31S:15
5. Przybelski RJ, Kant GJ, Bounds MJ, et al: Rat maze performance after resuscitation with cross-linked hemoglobin solution. J Lab Clin Med 1990; 115: 579-588
6. McKenzie JE, Cost EA, Scandling DM, et al: Effects of diaspirin cross-linked hemoglobin (DCLHb) on cardiac function and ECG in the swine. Biomaterials, Artificial Cells, and Immobilization Biotechnology 1992; 20: 683-687
7. Schultz SC, Craig MD, Burris DG, et al: The efficacy of diaspirin cross-linked hemoglobin solution resuscitation in a model of uncontrolled hemorrhage. J Trauma 1994; 37:408-412
8. Przybelski RJ, Malcolm DS, Burris DG, et al: Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1991; 117:143-151
9. Cole DJ, Schell RM, Drummond JC, et al: Focal cerebral ischemia in rats: Effect of hemodilution with α-α cross-linked hemoglobin versus albumin on brain injury and edema. Anesthesiology 1993; 78:335-342
10. Malcolm DS, Hamilton IN, Schultz SC, et al: Characterization of the hemodynamic response to intravenous diaspirin crosslinked hemoglobin solution in rats. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:91-107
11. Przybelski R, Kisicki JC, Daily E, et al: Diaspirin cross-linked hemoglobin (DCLHb™): Phase 1 clinical safety assessment in normal healthy volunteers. Crit Care Med 1994;22:A231
12. Hess JR, MacDonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74: 1769-1778
13. Przybelski RJ, Daily EK, Kisicki JC, et al: Phase I study of the safety and pharmacological effects of diaspirin cross-linked hemoglobin solution (DCLHb™). Crit Care Med 1996; 24: 1993-2000
14. Mourelatos MG, Enzer N, Ferguson JL, et al: The effects of diaspirin cross-linked hemoglobin in sepsis. Shock 1996; 5:141-148
15. Swan SK, Halstenson CE, Collins J, et al: Pharmacologic profile of diaspirin cross-linked hemoglobin (DCLHb) in hemodialysis patients. Am J Kidney Dis 1995; 26:918-923
16. Hamilton I, Schultz SC, Cole F, et al: Characterization of diaspirin cross-linked hemoglobin's pressor response. Crit Care Med 1992; 20:S106
17. Gulati A, Rebello S: Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 1994; 124:125-133
18. Gulati A, Sharma AC, Singh G: Role of endothelin in the cardiovascular effects of diaspirin cross-linked and stroma reduced hemoglobin. Crit Care Med 1996; 24:137-147
19. Schultz SC, Grady B, Cole F, et al: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301-308
20. Hunter LW, Tyce GM, Rorie DK: Norepinephrine release during vasoconstriction induced by cross-linked hemoglobin. Life Sci 1996; 59:131-140
21. Powell C, Schultz SC, Burris DG, et al: Resuscitation with diaspirin cross-linked hemoglobin (DCLHb) restores subcutaneous oxygen tension as well as blood in rats. Surgical Forum 1993; 44:40-42
22. Schultz SC, Hamilton Jr IA, Malcolm DS: Use of base deficit to compare resuscitation with lactated ringer's solution, haemaccel, whole blood and diaspirin cross linked hemoglobin following hemorrhage in rats. J Trauma 1993; 35:619-626
23. Frankel H, Nguyen H, Shea-Donohue T, et al: Diaspirin crosslinked hemoglobin is efficacious in gut resuscitation as measured by a GI tract optode. J Trauma 1996; 40:231-240
24. Schultz SC, Powell CC, Bernard E, et al: Diaspirin cross-linked hemoglobin (DCLHb™) attenuates bacterial translocation in rats. Artif Cells Blood Substit Immobil Biotechnol 1995; 23:647-664
25. Sharma AC, Gulati A: Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 1994; 123:299-308
26. Gulati A, Sharma AC, Burhop KE: Effect of stroma-free hemoglobin and diaspirin cross-linked hemoglobin on the regional circulation and systemic hemodynamics. Life Sci 1994; 55:827-837
27. Sloan E, Koenigsberg M, Bickell WH: The use of diaspirin cross-linked hemoglobin (DCLHb) solution in the treatment of hemorrhagic hypovolemic shock. Abstr. Academic Emergency Medicine 1995; 2:365
28. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest 1992; 101:1644-1655
29. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
30. Estep TN, Bobka E, Ebeling AA, et al: Novel aspects of diaspirin cross-linked hemoglobin synthesis and purification. Abstr. Biomaterials, Artificial Cells, and Artificial Organs 1989; 17:636
31. Nelson DJ, Bush SL, Marshall TA, et al: New blood product: Diaspirin cross-linked hemoglobin as a blood substitute. I. Charact erization and oxygen transport. Abstr. Transfusion 1992; 32S:8S
32. Vandegriff KD, Rohlfs RJ, Winslow RM: Effects of α-α cross-linking on oxygen binding to human hemoglobin. Abstr. Biomaterials, Artificial Cells, and Artificial Organs 1989; 17:644
33. Katsuyama SS, Cole DJ, Drummond JC, et al: Nitric oxide mediates the hypertensive response to a modified hemoglobin solution (DCLHb) in rats. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:1-7
34. Malcolm D, Kissinger D, Garrioch M: Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following severe haemorrhage in the rat. Biomaterials, Artificial Cells, and Immobilization Biotechnolgy 1992; 20: 495-498
35. Sharma AC, Gulati A: Yohimbine modulates diaspirin cross-linked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995; 23:874-884
36. Gulati A, Sharma AC: Prazosin blocks the pressor but not the regional circulatory effects of Diaspirin crosslinked haemoglobin. Life Sci 1994: 55:121-130
37. Sharma AC, Singh G, Gulati A: Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995; 269 (Heart Circ. Physiol. 38): H1379-H1388
38. Jia L; Bonaventura C, Bonaventura J, et al: S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996; 380: 221-226
39. Lorente JA, Landin L, Renes E, et al: Role of nitric oxide in hemodynamic changes in sepsis. Crit Care Med 1993; 21:759-767
40. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34-39
41. Wolfe TA, Dasta JF: Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann Pharmacother 1995; 29:36-46
42. Hata JS, Dellinger RP: Nitric oxide inhibition in the treatment of septic shock. Crit Care Med 1995; 23: 1621-1624
43. Robertson FM, Offner PJ, Ciceri DP, et al: Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129: 149-156
44. Friedman G, Berlot G, Kahn RJ, et al: Combined measurements of blood lactate concentrations and gastric intramucosal pH and their combinations in patients with severe sepsis. Crit Care Med 1995; 23:1184-1193
45. Griffiths E, Cortes A, Gilbert N, et al: Hemoglobin-based blood substitutes and sepsis. Lancet 1995; 345:158-160